Form 4: Trulieve President Granted Future-Dated RSUs

Trulieve Cannabis Corp. President Jason Pernell was granted 93,052 restricted stock units in a pre-planned transaction, vesting over two years.

Summary

• Jason Pernell, President of Trulieve Cannabis Corp., was granted 93,052 Subordinate Voting Shares in the form of Restricted Stock Units (RSUs) on August 12, 2025.
• This transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned future acquisition of equity securities.
• Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share.
• The RSUs will vest in two tranches: 50% on December 1, 2026, and the remaining 50% on December 1, 2027.
• Following this transaction, Jason Pernell directly beneficially owns 530,210 Subordinate Voting Shares.
• Additionally, Mr. Pernell indirectly holds 22,635 Multiple Voting Shares through the JASON B PERNELL TR KFP IRREVOCABLE TRUST DTD 03/02/2020.
• He also indirectly holds 22,636 Multiple Voting Shares through the KATHRYN FIELD PERNELL & TY ROOFNER TR JBP 2020 IRREVOCABLE TRUST DTD 01/06/2020.
• These Multiple Voting Shares are convertible into Subordinate Voting Shares on a one-for-100 basis, representing an aggregate potential of 4,527,100 Subordinate Voting Shares.

Sentiment

Score: 7

Explanation: The filing reports a routine, pre-planned equity grant to a key executive, which is generally viewed positively as it aligns management's interests with shareholders. It does not contain any negative surprises or significant new information beyond compensation details.

Positives

• The grant of Restricted Stock Units aligns the President's long-term incentives with shareholder interests, promoting sustained company performance.
• The transaction being pre-planned under a Rule 10b5-1 plan demonstrates a structured approach to executive compensation and reduces concerns about opportunistic insider trading.

Negatives

• The RSUs are future-dated and vest over several years, meaning there is no immediate liquidity or guaranteed value for the recipient until the vesting conditions are met.
• The value of the RSU grant is contingent on the future performance of Trulieve Cannabis Corp.'s stock price.

Future Outlook

The filing indicates a structured, long-term compensation plan for a key executive, with equity vesting scheduled for December 2026 and December 2027, aligning future performance with shareholder returns.

Industry Context

Equity grants to key executives are a standard practice across industries, including the rapidly evolving cannabis sector, to attract, retain, and incentivize top talent. Such grants align management's financial interests with the long-term success and stock performance of the company.

Comparison to Industry Standards

• The grant of RSUs is a common form of equity compensation in publicly traded companies, comparable to practices at other large cannabis operators like Curaleaf Holdings, Green Thumb Industries, or Cresco Labs, which also utilize equity incentives to align executive performance with shareholder value.
• The vesting schedule over two years is typical for executive equity grants, providing a balance between immediate incentive and long-term retention, similar to compensation structures observed in mature and growth-oriented industries.

Stakeholder Impact

• Shareholders: The RSU grant aligns the President's financial interests with the company's stock performance, potentially leading to more focused efforts on increasing shareholder value.
• Employees (Jason Pernell): Receives a significant long-term equity incentive, contingent on continued employment and company performance.

Next Steps

• The first tranche of 50% of the RSUs will vest on December 1, 2026.
• The remaining 50% of the RSUs will vest on December 1, 2027.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned equity compensation grant to a key executive. While positive for management alignment, it does not present new fundamental information or catalysts that would warrant a change in investment recommendation. It reinforces the long-term incentive structure for the company's leadership.

Keywords

Trulieve Cannabis Corp, TRUL, SEC Form 4, Restricted Stock Units, RSUs, Insider Transaction, Equity Compensation, Executive Compensation, Beneficial Ownership, Rule 10b5-1, Cannabis Industry